SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BCT'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AM6_A_HAEA555_1 (CARBONIC ANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 7 | HIS A 165HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 1am6A-4xz5A:29.7 | 1am6A-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AM6_A_HAEA555_1 (CARBONIC ANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 7 | HIS A 184HIS A 165HIS A 167THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 ( 4.4A) | 1.09A | 1am6A-4xz5A:29.7 | 1am6A-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AZM_A_AZMA262_1 (CARBONIC ANHYDRASE I) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 8 | HIS A 165HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.31A | 1azmA-4xz5A:29.3 | 1azmA-4xz5A:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BZM_A_MZMA262_1 (CARBONIC ANHYDRASE I) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 8 | HIS A 165HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.28A | 1bzmA-4xz5A:29.4 | 1bzmA-4xz5A:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BZM_A_MZMA262_1 (CARBONIC ANHYDRASE I) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 8 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.50A | 1bzmA-4xz5A:29.4 | 1bzmA-4xz5A:34.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C4D_A_DVAA6_0 (GRAMICIDIN A) |
2d3i | OVOTRANSFERRIN (Gallusgallus) | 3 / 3 | ALA A 462VAL A 465TRP A 464 | BCT A 690 (-3.2A)NoneNone | 0.85A | 1c4dA-2d3iA:undetectable1c4dB-2d3iA:undetectable | 1c4dA-2d3iA:4.571c4dB-2d3iA:4.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_N_TRPN81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 10 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.93A | 1c9sN-4yswA:undetectable1c9sO-4yswA:undetectable | 1c9sN-4yswA:5.061c9sO-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_P_TRPP81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.91A | 1c9sP-4yswA:undetectable1c9sQ-4yswA:undetectable | 1c9sP-4yswA:5.061c9sQ-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 10 | GLY A 915GLY A1006HIS A 884ALA A1079ILE A1007 | BCT A3006 (-3.9A)NoneNoneURC A3007 (-3.4A)None | 0.91A | 1c9sL-4yswA:undetectable1c9sV-4yswA:undetectable | 1c9sL-4yswA:5.061c9sV-4yswA:5.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CIL_A_ETSA263_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | HIS A 140GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 1cilA-4xz5A:29.7 | 1cilA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CIL_A_ETSA263_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.03A | 1cilA-4xz5A:29.7 | 1cilA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_A_AZMA400_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 11 | HIS A 165HIS A 167HIS A 184VAL A 186LEU A 194LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.43A | 1dmyA-4xz5A:26.5 | 1dmyA-4xz5A:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_A_AZMA400_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167VAL A 196LEU A 194LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.32A | 1dmyA-4xz5A:26.5 | 1dmyA-4xz5A:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_A_AZMA400_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 184HIS A 165HIS A 167TYR A 247THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.14A | 1dmyA-4xz5A:26.5 | 1dmyA-4xz5A:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_B_AZMB900_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | GLN A 143HIS A 167VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.21A | 1dmyB-4xz5A:26.5 | 1dmyB-4xz5A:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_B_AZMB900_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.34A | 1dmyB-4xz5A:26.5 | 1dmyB-4xz5A:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_B_AZMB900_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165HIS A 167VAL A 186LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 1dmyB-4xz5A:26.5 | 1dmyB-4xz5A:34.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DMY_B_AZMB900_1 (MURINE CARBONICANHYDRASE V) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 184HIS A 165HIS A 167TYR A 247THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.13A | 1dmyB-4xz5A:26.5 | 1dmyB-4xz5A:34.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | ALA A 78SER A 79SER A 126LYS A 216GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.61A | 1ghmA-4k0xA:18.1 | 1ghmA-4k0xA:25.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_Q_TRPQ81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.92A | 1gtfQ-4yswA:undetectable1gtfR-4yswA:undetectable | 1gtfQ-4yswA:5.061gtfR-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_S_TRPS81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.92A | 1gtfS-4yswA:undetectable1gtfT-4yswA:undetectable | 1gtfS-4yswA:5.061gtfT-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_T_TRPT81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.94A | 1gtnT-4yswA:undetectable1gtnU-4yswA:undetectable | 1gtnT-4yswA:5.061gtnU-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 12 | GLY A 915GLY A1006HIS A 884ALA A1079ILE A1007 | BCT A3006 (-3.9A)NoneNoneURC A3007 (-3.4A)None | 0.93A | 1gtnL-4yswA:undetectable1gtnV-4yswA:undetectable | 1gtnL-4yswA:5.061gtnV-4yswA:5.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_A_AZMA1400_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | GLN A 143HIS A 165HIS A 167HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.95A | 1jd0A-4xz5A:29.6 | 1jd0A-4xz5A:32.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_A_AZMA1400_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.44A | 1jd0A-4xz5A:29.6 | 1jd0A-4xz5A:32.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_A_AZMA1400_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.87A | 1jd0A-4xz5A:29.6 | 1jd0A-4xz5A:32.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_B_AZMB2401_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | GLN A 143HIS A 165HIS A 167GLU A 171HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.96A | 1jd0B-4xz5A:29.4 | 1jd0B-4xz5A:32.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_B_AZMB2401_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 252THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.16A | 1jd0B-4xz5A:29.4 | 1jd0B-4xz5A:32.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_B_AZMB2401_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.45A | 1jd0B-4xz5A:29.4 | 1jd0B-4xz5A:32.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1JD0_B_AZMB2401_1 (CARBONIC ANHYDRASEXII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.48A | 1jd0B-4xz5A:29.4 | 1jd0B-4xz5A:32.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LIK_A_ADNA799_1 (ADENOSINE KINASE) |
4q2h | PROLINE RACEMASEPROTEIN (Agrobacteriumtumefaciens) | 5 / 10 | THR A 257GLY A 173VAL A 147ALA A 91ILE A 222 | BCT A 401 (-2.8A)NoneNoneNoneNone | 0.92A | 1likA-4q2hA:undetectable | 1likA-4q2hA:24.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LIN_A_TFPA156_1 (CALMODULIN) |
2ist | RIBOSOMAL LARGESUBUNITPSEUDOURIDINESYNTHASE D (Escherichiacoli) | 5 / 8 | ILE A 86LEU A 84ILE A 96VAL A 148ILE A 94 | NoneBCT A 804 (-4.2A)NoneNoneNone | 1.47A | 1linA-2istA:undetectable | 1linA-2istA:19.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1OQ5_A_CELA701_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | ASN A 138HIS A 167LEU A 251THR A 252PRO A 255 | None ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.96A | 1oq5A-4xz5A:29.7 | 1oq5A-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1OQ5_A_CELA701_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 251THR A 252PRO A 255TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 0.38A | 1oq5A-4xz5A:29.7 | 1oq5A-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1OQ5_A_CELA701_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 167VAL A 196LEU A 251THR A 252PRO A 255 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.04A | 1oq5A-4xz5A:29.7 | 1oq5A-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_A_AZMA400_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.40A | 1rj6A-4xz5A:29.6 | 1rj6A-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_A_AZMA400_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.41A | 1rj6A-4xz5A:29.6 | 1rj6A-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_A_AZMA400_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 165HIS A 167LEU A 110THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.7A) | 1.36A | 1rj6A-4xz5A:29.6 | 1rj6A-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_A_AZMA400_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.42A | 1rj6A-4xz5A:29.6 | 1rj6A-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_B_AZMB401_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.40A | 1rj6B-4xz5A:29.3 | 1rj6B-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_B_AZMB401_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.41A | 1rj6B-4xz5A:29.3 | 1rj6B-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1RJ6_B_AZMB401_1 (CARBONIC ANHYDRASEXIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.42A | 1rj6B-4xz5A:29.3 | 1rj6B-4xz5A:31.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S2A_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TRP A 90HIS A 121GLU A 190TYR A 214SER A 215 | NoneBCT A1322 ( 3.9A)NoneNDP A1321 (-3.3A)NDP A1321 (-2.7A) | 0.26A | 1s2aA-2bgsA:39.7 | 1s2aA-2bgsA:33.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_O_TRPO81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 12 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.94A | 1utdO-4yswA:undetectable1utdP-4yswA:undetectable | 1utdO-4yswA:5.061utdP-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_P_TRPP81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.93A | 1utdP-4yswA:undetectable1utdQ-4yswA:undetectable | 1utdP-4yswA:5.061utdQ-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_S_TRPS81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 11 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.92A | 1utdS-4yswA:undetectable1utdT-4yswA:undetectable | 1utdS-4yswA:5.061utdT-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_U_TRPU81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 5 / 10 | GLY A1006HIS A 884ALA A1079ILE A1007GLY A 915 | NoneNoneURC A3007 (-3.4A)NoneBCT A3006 (-3.9A) | 0.95A | 1utdU-4yswA:undetectable1utdV-4yswA:undetectable | 1utdU-4yswA:5.061utdV-4yswA:5.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XZX_X_T3X500_1 (THYROID HORMONERECEPTOR BETA-1) |
3v7p | AMIDOHYDROLASEFAMILY PROTEIN (Nitratiruptorsp.SB155-2) | 5 / 12 | ILE A 341ALA A 346LEU A 293ILE A 296HIS A 278 | NoneNoneBCT A 435 (-3.9A)NoneNone | 1.22A | 1xzxX-3v7pA:undetectable | 1xzxX-3v7pA:20.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YDA_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 10 | GLN A 163HIS A 165HIS A 184VAL A 186VAL A 196THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.37A | 1ydaA-4xz5A:29.2 | 1ydaA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YDB_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 11 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.30A | 1ydbA-4xz5A:29.3 | 1ydbA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YDB_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 167HIS A 184VAL A 196THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.91A | 1ydbA-4xz5A:29.3 | 1ydbA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YDD_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | GLN A 143HIS A 167VAL A 186THR A 252THR A 253 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.17A | 1yddA-4xz5A:29.7 | 1yddA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YDD_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.27A | 1yddA-4xz5A:29.7 | 1yddA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z9Y_A_FUNA500_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.35A | 1z9yA-4xz5A:29.6 | 1z9yA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGF_A_TRUA300_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | ASN A 138GLN A 143HIS A 167VAL A 186THR A 253 | NoneNone ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.29A | 1zgfA-4xz5A:29.6 | 1zgfA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGF_A_TRUA300_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | ASN A 138HIS A 167VAL A 186LEU A 251THR A 252THR A 253 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 1zgfA-4xz5A:29.6 | 1zgfA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGF_A_TRUA300_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 1zgfA-4xz5A:29.6 | 1zgfA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGF_A_TRUA300_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.47A | 1zgfA-4xz5A:29.6 | 1zgfA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZSB_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | GLN A 143HIS A 165HIS A 167GLU A 171HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.99A | 1zsbA-4xz5A:29.8 | 1zsbA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZSB_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 252THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.16A | 1zsbA-4xz5A:29.8 | 1zsbA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZSB_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.38A | 1zsbA-4xz5A:29.8 | 1zsbA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AW1_A_COXA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 194VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 2aw1A-4xz5A:29.6 | 2aw1A-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AW1_A_COXA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167VAL A 196LEU A 194LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.30A | 2aw1A-4xz5A:29.6 | 2aw1A-4xz5A:32.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EJ3_C_GBNC1414_1 (BRANCHED-CHAIN AMINOACIDAMINOTRANSFERASE) |
2d3i | OVOTRANSFERRIN (Gallusgallus) | 5 / 8 | TYR A 431GLY A 523GLY A 463THR A 461ALA A 462 | AL A 689 ( 4.2A)NoneBCT A 690 (-3.9A)BCT A 690 (-4.3A)BCT A 690 (-3.2A) | 1.33A | 2ej3C-2d3iA:undetectable | 2ej3C-2d3iA:16.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EZ7_A_DHIA301_0 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 6 | TRP A 78GLN A 163THR A 253PRO A 255 | NoneNoneBCT A 402 ( 4.4A)None | 0.47A | 2ez7A-4xz5A:29.4 | 2ez7A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2GEH_A_NHYA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 8 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.34A | 2gehA-4xz5A:29.6 | 2gehA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2GEH_A_NHYA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 8 | HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 0.92A | 2gehA-4xz5A:29.6 | 2gehA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2H4N_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | GLN A 143HIS A 167HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.01A | 2h4nA-4xz5A:29.8 | 2h4nA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2H4N_A_AZMA264_1 (CARBONIC ANHYDRASEII) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 9 | GLN A 163HIS A 167HIS A 184VAL A 186THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.49A | 2h4nA-4xz5A:29.8 | 2h4nA-4xz5A:32.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HKK_A_ALEA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 6 | ASN A 138HIS A 140GLN A 163THR A 253 | NoneNoneNoneBCT A 402 ( 4.4A) | 0.38A | 2hkkA-4xz5A:29.4 | 2hkkA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2INE_A_PACA317_0 (ALDOSE REDUCTASE) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 4 / 5 | TRP A 32TYR A 60HIS A 121TRP A 122 | BCT A1322 ( 3.3A)BCT A1322 ( 4.4A)BCT A1322 ( 3.9A)BCT A1322 (-4.3A) | 0.25A | 2ineA-2bgsA:42.2 | 2ineA-2bgsA:38.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ISF_A_PACA317_0 (ALDOSE REDUCTASE) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 4 / 5 | TRP A 32TYR A 60HIS A 121TRP A 122 | BCT A1322 ( 3.3A)BCT A1322 ( 4.4A)BCT A1322 ( 3.9A)BCT A1322 (-4.3A) | 0.27A | 2isfA-2bgsA:42.0 | 2isfA-2bgsA:38.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2IT4_A_PPFA500_1 (CARBONIC ANHYDRASE 1) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 8 | HIS A 165HIS A 167HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 0.26A | 2it4A-4xz5A:28.9 | 2it4A-4xz5A:34.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2IT4_A_PPFA500_1 (CARBONIC ANHYDRASE 1) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 8 | HIS A 167VAL A 186LEU A 251THR A 252 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 0.89A | 2it4A-4xz5A:28.9 | 2it4A-4xz5A:34.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2POU_A_I7AA1000_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | ASN A 138GLN A 143HIS A 167VAL A 186THR A 253 | NoneNone ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.21A | 2pouA-4xz5A:29.6 | 2pouA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2POU_A_I7AA1000_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | ASN A 138HIS A 167VAL A 186LEU A 251THR A 252THR A 253 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.01A | 2pouA-4xz5A:29.6 | 2pouA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2POU_A_I7AA1000_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 2pouA-4xz5A:29.6 | 2pouA-4xz5A:32.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y6R_B_CTCB1385_0 (TETX2 PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | BCT A3006 (-3.0A)URC A3007 ( 3.4A)BCT A3006 (-3.9A)None | 0.81A | 2y6rB-4yswA:undetectable | 2y6rB-4yswA:14.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YS6_A_GLYA431_0 (PHOSPHORIBOSYLGLYCINAMIDE SYNTHETASE) |
4mv3 | BIOTIN CARBOXYLASE (Haemophilusinfluenzae) | 4 / 8 | LYS A 238ASN A 290ARG A 292GLU A 296 | BCT A 503 ( 3.8A)ACP A 501 (-3.9A)BCT A 503 (-2.7A)BCT A 503 (-3.4A) | 0.96A | 2ys6A-4mv3A:28.4 | 2ys6A-4mv3A:26.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YVL_C_SAMC604_0 (HYPOTHETICAL PROTEIN) |
2d3i | OVOTRANSFERRIN (Gallusgallus) | 5 / 12 | ILE A 127GLY A 124ALA A 94VAL A 161ASP A 60 | NoneBCT A 688 (-3.8A)NoneNone AL A 687 ( 2.9A) | 0.93A | 2yvlC-2d3iA:undetectable | 2yvlC-2d3iA:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZJ0_A_2FAA500_1 (ADENOSYLHOMOCYSTEINASE) |
4zi6 | CYTOSOLAMINOPEPTIDASE (Helicobacterpylori) | 5 / 12 | LEU A 260ASP A 281LYS A 270ASP A 340LEU A 368 | ZN A 501 ( 4.8A) ZN A 501 (-2.4A) ZN A 502 (-3.6A) ZN A 502 (-2.9A)BCT A 503 (-4.5A) | 1.24A | 2zj0A-4zi6A:undetectable | 2zj0A-4zi6A:22.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BL1_A_BL1A300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.37A | 3bl1A-4xz5A:29.3 | 3bl1A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BL1_A_BL1A300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.50A | 3bl1A-4xz5A:29.3 | 3bl1A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3BL1_A_BL1A300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 167VAL A 186LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 3bl1A-4xz5A:29.3 | 3bl1A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CAJ_A_EZLA265_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.36A | 3cajA-4xz5A:29.7 | 3cajA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CAJ_A_EZLA265_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 165HIS A 184THR A 252PRO A 254TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)NoneNone | 1.27A | 3cajA-4xz5A:29.7 | 3cajA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CAJ_A_EZLA265_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253PRO A 255 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.01A | 3cajA-4xz5A:29.7 | 3cajA-4xz5A:32.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CSJ_B_CBLB211_0 (GLUTATHIONES-TRANSFERASE P) |
5lhk | LEUCINEAMINOPEPTIDASE 2,CHLOROPLASTIC (Streptomycessp.BC16019) | 5 / 9 | PRO A 312VAL A 349GLY A 226ILE A 339GLY A 346 | NoneNoneNoneNoneBCT A 603 (-3.3A) | 1.43A | 3csjB-5lhkA:undetectable | 3csjB-5lhkA:19.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CZV_A_AZMA263_1 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.53A | 3czvA-4xz5A:29.83czvB-4xz5A:29.5 | 3czvA-4xz5A:30.913czvB-4xz5A:30.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CZV_B_AZMB263_1 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | GLN A 143HIS A 165HIS A 167HIS A 184THR A 252 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A) | 1.05A | 3czvB-4xz5A:29.5 | 3czvB-4xz5A:30.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CZV_B_AZMB263_1 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.48A | 3czvB-4xz5A:29.5 | 3czvB-4xz5A:30.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CZV_B_AZMB263_1 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.46A | 3czvB-4xz5A:29.5 | 3czvB-4xz5A:30.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CZV_B_AZMB263_1 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.38A | 3czvB-4xz5A:29.5 | 3czvB-4xz5A:30.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DAZ_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.34A | 3dazA-4xz5A:29.8 | 3dazA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DAZ_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.90A | 3dazA-4xz5A:29.8 | 3dazA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DAZ_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.44A | 3dazA-4xz5A:29.8 | 3dazA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DC3_A_AZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | GLN A 143HIS A 165HIS A 167GLU A 171HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 3dc3A-4xz5A:29.9 | 3dc3A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DC3_A_AZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 252THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.16A | 3dc3A-4xz5A:29.9 | 3dc3A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DC3_A_AZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.37A | 3dc3A-4xz5A:29.9 | 3dc3A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DC3_A_AZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 3dc3A-4xz5A:29.9 | 3dc3A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCS_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | GLN A 143HIS A 165HIS A 167HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.01A | 3dcsA-4xz5A:29.9 | 3dcsA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCS_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.42A | 3dcsA-4xz5A:29.9 | 3dcsA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCS_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.92A | 3dcsA-4xz5A:29.9 | 3dcsA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCS_A_MZMA263_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.41A | 3dcsA-4xz5A:29.9 | 3dcsA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCW_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.35A | 3dcwA-4xz5A:29.9 | 3dcwA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCW_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 165HIS A 184THR A 252PRO A 254TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)NoneNone | 1.29A | 3dcwA-4xz5A:29.9 | 3dcwA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DCW_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 10 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 1.42A | 3dcwA-4xz5A:29.9 | 3dcwA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DD0_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.35A | 3dd0A-4xz5A:29.8 | 3dd0A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DD0_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 10 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)NoneNone | 1.49A | 3dd0A-4xz5A:29.8 | 3dd0A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DD0_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 3dd0A-4xz5A:29.8 | 3dd0A-4xz5A:32.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DGQ_A_EAAA211_1 (GLUTATHIONES-TRANSFERASE P) |
5fbh | EXTRACELLULARCALCIUM-SENSINGRECEPTOR (Homosapiens) | 4 / 5 | ARG B 66ILE B 416TYR B 167THR B 186 | TCR B 609 ( 3.6A)BCT B 604 (-4.5A)NoneNone | 1.49A | 3dgqA-5fbhB:undetectable | 3dgqA-5fbhB:17.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.43A | 3f4xA-4xz5A:29.4 | 3f4xA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | ASN A 138HIS A 167LEU A 251THR A 252THR A 253PRO A 255 | None ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.95A | 3f4xA-4xz5A:29.4 | 3f4xA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | ASN A 138HIS A 167VAL A 186LEU A 251THR A 253PRO A 255 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)None | 0.91A | 3f4xA-4xz5A:29.4 | 3f4xA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165VAL A 196LEU A 251THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)NoneNone | 1.37A | 3f4xA-4xz5A:29.4 | 3f4xA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3F4X_A_KLTA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253PRO A 255 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.99A | 3f4xA-4xz5A:29.4 | 3f4xA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138HIS A 140GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.46A | 3fw3A-4xz5A:27.5 | 3fw3A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 140GLN A 143HIS A 165HIS A 167THR A 252THR A 253 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.05A | 3fw3A-4xz5A:27.5 | 3fw3A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 140HIS A 165VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.47A | 3fw3A-4xz5A:27.5 | 3fw3A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.42A | 3fw3A-4xz5A:27.5 | 3fw3A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_B_ETSB303_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.33A | 3fw3B-4xz5A:27.4 | 3fw3B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_B_ETSB303_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.50A | 3fw3B-4xz5A:27.4 | 3fw3B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3FW3_B_ETSB303_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.91A | 3fw3B-4xz5A:27.4 | 3fw3B-4xz5A:31.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GLQ_A_RABA602_1 (ADENOSYLHOMOCYSTEINASE) |
4zi6 | CYTOSOLAMINOPEPTIDASE (Helicobacterpylori) | 5 / 12 | LEU A 260ASP A 281LYS A 270ASP A 340LEU A 368 | ZN A 501 ( 4.8A) ZN A 501 (-2.4A) ZN A 502 (-3.6A) ZN A 502 (-2.9A)BCT A 503 (-4.5A) | 1.20A | 3glqA-4zi6A:undetectable | 3glqA-4zi6A:24.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | ASN A 138GLN A 143HIS A 167VAL A 186THR A 253 | NoneNone ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.20A | 3hkuA-4xz5A:29.6 | 3hkuA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)None | 0.35A | 3hkuA-4xz5A:29.6 | 3hkuA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | ASN A 138HIS A 167VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 0.92A | 3hkuA-4xz5A:29.6 | 3hkuA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 251THR A 252 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.49A | 3hkuA-4xz5A:29.6 | 3hkuA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HKU_A_TORA300_2 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 3 / 3 | GLU A 171HIS A 184THR A 252 | ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A) | 0.17A | 3hkuA-4xz5A:29.6 | 3hkuA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS4_A_AZMA701_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.27A | 3hs4A-4xz5A:29.8 | 3hs4A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS4_A_AZMA701_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.47A | 3hs4A-4xz5A:29.8 | 3hs4A-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_A_AZMA263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 3iaiA-4xz5A:29.9 | 3iaiA-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_A_AZMA263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.90A | 3iaiA-4xz5A:29.9 | 3iaiA-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_B_AZMB263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 3iaiB-4xz5A:30.0 | 3iaiB-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_B_AZMB263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.89A | 3iaiB-4xz5A:30.0 | 3iaiB-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_C_AZMC263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 3iaiC-4xz5A:30.0 | 3iaiC-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_C_AZMC263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.88A | 3iaiC-4xz5A:30.0 | 3iaiC-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_D_AZMD263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 3iaiD-4xz5A:30.1 | 3iaiD-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_D_AZMD263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.87A | 3iaiD-4xz5A:30.1 | 3iaiD-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAI_D_AZMD263_1 (CARBONIC ANHYDRASE 9) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.43A | 3iaiD-4xz5A:30.1 | 3iaiD-4xz5A:35.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KWA_A_SPMA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.40A | 3kwaA-4xz5A:29.3 | 3kwaA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KWA_A_SPMA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 165HIS A 184LEU A 251THR A 252PRO A 254TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 1.38A | 3kwaA-4xz5A:29.3 | 3kwaA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KWA_A_SPMA300_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 184VAL A 196LEU A 251THR A 252THR A 253PRO A 255 | ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.13A | 3kwaA-4xz5A:29.3 | 3kwaA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LXE_A_TORA262_1 (CARBONIC ANHYDRASE 1) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | GLN A 163HIS A 165HIS A 167VAL A 196LEU A 251THR A 252TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.51A | 3lxeA-4xz5A:29.2 | 3lxeA-4xz5A:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LXE_B_TORB262_1 (CARBONIC ANHYDRASE 1) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | GLN A 163HIS A 165HIS A 167VAL A 196LEU A 251THR A 252TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.50A | 3lxeB-4xz5A:29.1 | 3lxeB-4xz5A:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MDZ_A_EZLA264_1 (CARBONIC ANHYDRASE 7) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.34A | 3mdzA-4xz5A:29.3 | 3mdzA-4xz5A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MDZ_A_EZLA264_1 (CARBONIC ANHYDRASE 7) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253PRO A 255 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.95A | 3mdzA-4xz5A:29.3 | 3mdzA-4xz5A:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ML5_A_AZMA264_1 (CARBONIC ANHYDRASE 7) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.27A | 3ml5A-4xz5A:29.9 | 3ml5A-4xz5A:32.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ML5_A_AZMA264_1 (CARBONIC ANHYDRASE 7) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.95A | 3ml5A-4xz5A:29.9 | 3ml5A-4xz5A:32.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.88A | 3ny4A-4k0xA:19.1 | 3ny4A-4k0xA:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R24_A_SAMA302_0 (2'-O-METHYLTRANSFERASE) |
3v7p | AMIDOHYDROLASEFAMILY PROTEIN (Nitratiruptorsp.SB155-2) | 5 / 12 | GLY A 289SER A 282GLY A 76LEU A 291ASP A 292 | NoneNoneNoneNoneBCT A 435 (-4.6A) | 1.46A | 3r24A-3v7pA:undetectable | 3r24A-3v7pA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R43_A_ID8A332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TYR A 60TRP A 90HIS A 121ASN A 167TYR A 214 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-3.3A) | 0.26A | 3r43A-2bgsA:39.9 | 3r43A-2bgsA:34.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R6I_A_JMSA332_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TYR A 60TRP A 90HIS A 121ASN A 167TYR A 214 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-3.3A) | 0.23A | 3r6iA-2bgsA:39.8 | 3r6iA-2bgsA:34.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RX3_A_SUZA317_1 (ALDOSE REDUCTASE) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 10 | TRP A 32TYR A 60HIS A 121TRP A 122LEU A 300 | BCT A1322 ( 3.3A)BCT A1322 ( 4.4A)BCT A1322 ( 3.9A)BCT A1322 (-4.3A)None | 1.04A | 3rx3A-2bgsA:42.4 | 3rx3A-2bgsA:39.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S3G_A_TLTA317_1 (ALDOSE REDUCTASE) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 4 / 7 | TRP A 32TYR A 60HIS A 121TRP A 122 | BCT A1322 ( 3.3A)BCT A1322 ( 4.4A)BCT A1322 ( 3.9A)BCT A1322 (-4.3A) | 0.29A | 3s3gA-2bgsA:42.4 | 3s3gA-2bgsA:39.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S54_B_017B201_2 (PROTEASE) |
3h8f | CYTOSOLAMINOPEPTIDASE (Pseudomonasputida) | 6 / 12 | LEU A 247GLY A 266ASP A 373GLY A 352ILE A 269ILE A 226 | NoneNoneNoneBCT A 504 (-3.3A) ZN A 501 ( 4.8A)None | 1.48A | 3s54B-3h8fA:undetectable | 3s54B-3h8fA:11.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | ALA A 78SER A 79SER A 126LYS A 216THR A 217GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.52A | 3sh8A-4k0xA:19.6 | 3sh8A-4k0xA:24.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | ALA A 78SER A 79SER A 126LYS A 216GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.50A | 3sh8B-4k0xA:19.7 | 3sh8B-4k0xA:24.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UG8_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 6 / 12 | TYR A 60TRP A 90HIS A 121ASN A 167TYR A 214SER A 215 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-3.3A)NDP A1321 (-2.7A) | 0.36A | 3ug8A-2bgsA:39.8 | 3ug8A-2bgsA:34.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TRP A 90HIS A 121TYR A 214SER A 215PHE A 301 | NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-2.7A)None | 1.07A | 3ugrA-2bgsA:39.6 | 3ugrA-2bgsA:34.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3UGR_A_IMNA2001_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TRP A 90HIS A 121TYR A 214SER A 215SER A 219 | NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-2.7A)NDP A1321 (-2.7A) | 0.75A | 3ugrA-2bgsA:39.6 | 3ugrA-2bgsA:34.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3V2J_A_AZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.28A | 3v2jA-4xz5A:29.9 | 3v2jA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3V2M_A_AZMA303_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.26A | 3v2mA-4xz5A:29.7 | 3v2mA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3V2M_A_AZMA303_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.46A | 3v2mA-4xz5A:29.7 | 3v2mA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3V2M_A_AZMA303_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.90A | 3v2mA-4xz5A:29.7 | 3v2mA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3V2M_A_AZMA303_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.39A | 3v2mA-4xz5A:29.7 | 3v2mA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3V35_A_NTIA317_1 (ALDOSE REDUCTASE) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 4 / 8 | TRP A 32TRP A 90HIS A 121TRP A 122 | BCT A1322 ( 3.3A)NoneBCT A1322 ( 3.9A)BCT A1322 (-4.3A) | 0.29A | 3v35A-2bgsA:42.7 | 3v35A-2bgsA:39.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V3N_B_MIYB2001_1 (TETX2 PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | BCT A3006 (-3.0A)URC A3007 ( 3.4A)BCT A3006 (-3.9A)None | 0.75A | 3v3nB-4yswA:undetectable | 3v3nB-4yswA:13.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V3N_C_MIYC2001_1 (TETX2 PROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 4 / 8 | GLN A 918PHE A 914GLY A 915GLY A 800 | BCT A3006 (-3.0A)URC A3007 ( 3.4A)BCT A3006 (-3.9A)None | 0.74A | 3v3nC-4yswA:undetectable | 3v3nC-4yswA:13.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W6H_A_AZMA303_1 (CARBONIC ANHYDRASE 1) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 8 | GLN A 163HIS A 165HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.44A | 3w6hA-4xz5A:29.2 | 3w6hA-4xz5A:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3W6H_B_AZMB303_1 (CARBONIC ANHYDRASE 1) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 9 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184LEU A 251THR A 252TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.43A | 3w6hB-4xz5A:29.2 | 3w6hB-4xz5A:34.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WEM_A_ACRA1001_1 (ALPHA-GLUCOSIDASE) |
5lhk | LEUCINEAMINOPEPTIDASE 2,CHLOROPLASTIC (Streptomycessp.BC16019) | 5 / 12 | ASP A 440ALA A 445PHE A 390ASP A 284ARG A 347 | NoneNoneNone MN A 601 (-2.2A)BCT A 603 (-3.8A) | 1.31A | 3wemA-5lhkA:undetectable | 3wemA-5lhkA:20.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZNC_A_BZ1A500_1 (CARBONIC ANHYDRASEIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | GLN A 143HIS A 165HIS A 167HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.02A | 3zncA-4xz5A:27.3 | 3zncA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZNC_A_BZ1A500_1 (CARBONIC ANHYDRASEIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.46A | 3zncA-4xz5A:27.3 | 3zncA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZNC_A_BZ1A500_1 (CARBONIC ANHYDRASEIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.47A | 3zncA-4xz5A:27.3 | 3zncA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZNC_A_BZ1A500_1 (CARBONIC ANHYDRASEIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.88A | 3zncA-4xz5A:27.3 | 3zncA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZNC_A_BZ1A500_1 (CARBONIC ANHYDRASEIV) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.44A | 3zncA-4xz5A:27.3 | 3zncA-4xz5A:32.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A99_D_MIYD393_1 (TETX2 PROTEIN) |
2i4c | BICARBONATETRANSPORTER (Synechocystissp.PCC6803) | 4 / 5 | ILE A 115GLN A 96ILE A 66GLU A 271 | NoneNoneNoneBCT A 460 ( 2.9A) | 1.15A | 4a99D-2i4cA:undetectable | 4a99D-2i4cA:23.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AQ7_A_LEUA902_0 (LEUCINE--TRNA LIGASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 7 | LEU A 251GLU A 182HIS A 184HIS A 165 | BCT A 402 (-3.8A)None ZN A 401 ( 3.1A) ZN A 401 ( 3.2A) | 1.24A | 4aq7A-4xz5A:undetectable | 4aq7A-4xz5A:14.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_A_SANA300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.23A | 4coqA-4xz5A:34.7 | 4coqA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_A_SANA300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 10 | GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.42A | 4coqA-4xz5A:34.7 | 4coqA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_A_SANA300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 4coqA-4xz5A:34.7 | 4coqA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_A_SANA300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.95A | 4coqA-4xz5A:34.7 | 4coqA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_B_SANB300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.24A | 4coqB-4xz5A:34.4 | 4coqB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_B_SANB300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.47A | 4coqB-4xz5A:34.4 | 4coqB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_B_SANB300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.97A | 4coqB-4xz5A:34.4 | 4coqB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COQ_B_SANB300_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.42A | 4coqB-4xz5A:34.4 | 4coqB-4xz5A:42.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4mv3 | BIOTIN CARBOXYLASE (Haemophilusinfluenzae) | 5 / 12 | ARG A 338GLU A 241LEU A 308GLU A 211ASN A 290 | BCT A 503 (-3.5A)NoneNoneNoneACP A 501 (-3.9A) | 1.47A | 4cpzB-4mv3A:undetectable | 4cpzB-4mv3A:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4mv3 | BIOTIN CARBOXYLASE (Haemophilusinfluenzae) | 5 / 12 | ARG A 338GLU A 241LEU A 308ALA A 272GLU A 211 | BCT A 503 (-3.5A)NoneNoneNoneNone | 1.30A | 4cpzD-4mv3A:undetectable | 4cpzD-4mv3A:20.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E3H_A_HQEA303_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | GLN A 163VAL A 186LEU A 194VAL A 196LEU A 251THR A 252THR A 253VAL A 260TRP A 262 | NoneNoneNoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.42A | 4e3hA-4xz5A:29.7 | 4e3hA-4xz5A:32.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 5 / 10 | SER A 126LYS A 216THR A 217GLY A 218ARG A 259 | BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.85A | 4fh2A-4k0xA:18.3 | 4fh2A-4k0xA:24.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G0C_A_AZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 163HIS A 165GLU A 182VAL A 186THR A 252 | None ZN A 401 ( 3.2A)NoneNoneBCT A 402 (-3.7A) | 1.26A | 4g0cA-4xz5A:29.8 | 4g0cA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G0C_A_AZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 4g0cA-4xz5A:29.8 | 4g0cA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G0C_A_AZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.88A | 4g0cA-4xz5A:29.8 | 4g0cA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_A_AZMA302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.24A | 4g7aA-4xz5A:32.8 | 4g7aA-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_A_AZMA302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.27A | 4g7aA-4xz5A:32.8 | 4g7aA-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_A_AZMA302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.48A | 4g7aA-4xz5A:32.8 | 4g7aA-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_A_AZMA302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.90A | 4g7aA-4xz5A:32.8 | 4g7aA-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_B_AZMB302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.27A | 4g7aB-4xz5A:32.7 | 4g7aB-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_B_AZMB302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 4g7aB-4xz5A:32.7 | 4g7aB-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_B_AZMB302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.50A | 4g7aB-4xz5A:32.7 | 4g7aB-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G7A_B_AZMB302_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.04A | 4g7aB-4xz5A:32.7 | 4g7aB-4xz5A:38.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JQ4_B_IMNB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 10 | TYR A 60HIS A 121ASN A 167TYR A 214LEU A 295 | BCT A1322 ( 4.4A)BCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-3.3A)NDP A1321 (-4.8A) | 0.68A | 4jq4B-2bgsA:39.8 | 4jq4B-2bgsA:32.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JTR_A_IBPA401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 4 / 8 | TYR A 60TRP A 90HIS A 121LEU A 295 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NDP A1321 (-4.8A) | 0.70A | 4jtrA-2bgsA:40.0 | 4jtrA-2bgsA:32.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K0S_A_AZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.30A | 4k0sA-4xz5A:29.8 | 4k0sA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K0S_A_AZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 4k0sA-4xz5A:29.8 | 4k0sA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K0Z_A_MZMA308_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.39A | 4k0zA-4xz5A:29.6 | 4k0zA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K0Z_A_MZMA308_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 165HIS A 184LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 1.50A | 4k0zA-4xz5A:29.6 | 4k0zA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K0Z_A_MZMA308_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253PRO A 255 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.06A | 4k0zA-4xz5A:29.6 | 4k0zA-4xz5A:32.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K13_A_ETSA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 194VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.30A | 4k13A-4xz5A:29.8 | 4k13A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K13_A_ETSA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 194LEU A 251THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.43A | 4k13A-4xz5A:29.8 | 4k13A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K13_A_ETSA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.46A | 4k13A-4xz5A:29.8 | 4k13A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K13_A_ETSA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167VAL A 196LEU A 194LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.32A | 4k13A-4xz5A:29.8 | 4k13A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4K13_A_ETSA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 184HIS A 172VAL A 196LEU A 194LEU A 251THR A 252 | ZN A 401 ( 3.1A)NoneNoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.47A | 4k13A-4xz5A:29.8 | 4k13A-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LB0_A_ACTA401_0 (UNCHARACTERIZEDPROTEIN) |
4q2h | PROLINE RACEMASEPROTEIN (Agrobacteriumtumefaciens) | 8 / 9 | SER A 93GLY A 94SER A 95TYR A 177ASP A 251SER A 253GLY A 256THR A 257 | BCT A 401 (-3.5A)BCT A 401 (-3.6A)BCT A 401 (-3.4A)CSO A 255 ( 4.8A)CSO A 255 (-3.5A)CSO A 255 ( 3.0A)CSO A 255 (-2.4A)BCT A 401 (-2.8A) | 0.11A | 4lb0A-4q2hA:59.7 | 4lb0A-4q2hA:77.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LB0_A_ACTA401_0 (UNCHARACTERIZEDPROTEIN) |
4q2h | PROLINE RACEMASEPROTEIN (Agrobacteriumtumefaciens) | 5 / 9 | SER A 93GLY A 94SER A 95TYR A 227SER A 253 | BCT A 401 (-3.5A)BCT A 401 (-3.6A)BCT A 401 (-3.4A)NoneCSO A 255 ( 3.0A) | 0.97A | 4lb0A-4q2hA:59.7 | 4lb0A-4q2hA:77.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LB2_A_DM5A602_1 (SERUM ALBUMIN) |
2ist | RIBOSOMAL LARGESUBUNITPSEUDOURIDINESYNTHASE D (Escherichiacoli) | 4 / 7 | PRO A 302VAL A 306MET A 305PHE A 274 | NoneBCT A 803 ( 4.1A)NoneNone | 1.07A | 4lb2A-2istA:undetectable | 4lb2A-2istA:18.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LU3_A_AZMA302_1 (CARBONIC ANHYDRASE14) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171LEU A 251THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)BCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.13A | 4lu3A-4xz5A:29.4 | 4lu3A-4xz5A:30.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LU3_A_AZMA302_1 (CARBONIC ANHYDRASE14) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.30A | 4lu3A-4xz5A:29.4 | 4lu3A-4xz5A:30.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LU3_A_AZMA302_1 (CARBONIC ANHYDRASE14) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.83A | 4lu3A-4xz5A:29.4 | 4lu3A-4xz5A:30.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2R_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.38A | 4m2rA-4xz5A:29.9 | 4m2rA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2R_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165VAL A 196LEU A 251THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)NoneNone | 1.30A | 4m2rA-4xz5A:29.9 | 4m2rA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2U_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | TRP A 78HIS A 140GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 4m2uA-4xz5A:29.9 | 4m2uA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2U_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | TRP A 78HIS A 140HIS A 165VAL A 196LEU A 251THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)None | 1.41A | 4m2uA-4xz5A:29.9 | 4m2uA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2U_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | TRP A 78HIS A 140HIS A 167LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.33A | 4m2uA-4xz5A:29.9 | 4m2uA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2U_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | TRP A 89HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)None | 1.41A | 4m2uA-4xz5A:29.9 | 4m2uA-4xz5A:33.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.40A | 4m2vA-4xz5A:29.9 | 4m2vA-4xz5A:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167VAL A 196GLY A 192LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 4m2vA-4xz5A:29.9 | 4m2vA-4xz5A:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | LEU A 162GLN A 163HIS A 165HIS A 167VAL A 186GLY A 192LEU A 251THR A 252THR A 253 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.24A | 4m2vA-4xz5A:29.9 | 4m2vA-4xz5A:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | LEU A 162GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.60A | 4m2vA-4xz5A:29.9 | 4m2vA-4xz5A:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2W_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167HIS A 184LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.46A | 4m2wA-4xz5A:29.9 | 4m2wA-4xz5A:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2W_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 12 / 12 | LEU A 162GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 194VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.59A | 4m2wA-4xz5A:29.9 | 4m2wA-4xz5A:33.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M2W_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | LEU A 162GLN A 163HIS A 165HIS A 167VAL A 186LEU A 194LEU A 251THR A 253 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.47A | 4m2wA-4xz5A:29.9 | 4m2wA-4xz5A:33.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MM9_A_FVXA603_1 (TRANSPORTER) |
1vrg | PROPIONYL-COACARBOXYLASE, BETASUBUNIT (Thermotogamaritima) | 5 / 11 | VAL A 174ALA A 173TYR A 175GLY A 196GLY A 132 | NoneNoneNoneBCT A 517 (-3.7A)None | 1.20A | 4mm9A-1vrgA:0.0 | 4mm9A-1vrgA:23.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MV7_A_PPFA501_1 (BIOTIN CARBOXYLASE) |
4mv3 | BIOTIN CARBOXYLASE (Haemophilusinfluenzae) | 6 / 7 | LYS A 238ASN A 290ARG A 292VAL A 295GLU A 296ARG A 338 | BCT A 503 ( 3.8A)ACP A 501 (-3.9A)BCT A 503 (-2.7A)BCT A 503 (-3.8A)BCT A 503 (-3.4A)BCT A 503 (-3.5A) | 0.35A | 4mv7A-4mv3A:65.5 | 4mv7A-4mv3A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MV7_A_PPFA501_1 (BIOTIN CARBOXYLASE) |
4mv3 | BIOTIN CARBOXYLASE (Haemophilusinfluenzae) | 6 / 7 | LYS A 238ASN A 290GLN A 294VAL A 295GLU A 296ARG A 338 | BCT A 503 ( 3.8A)ACP A 501 (-3.9A)BCT A 503 (-4.3A)BCT A 503 (-3.8A)BCT A 503 (-3.4A)BCT A 503 (-3.5A) | 0.69A | 4mv7A-4mv3A:65.5 | 4mv7A-4mv3A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N16_A_CHDA301_0 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 8 | GLN A 163HIS A 165HIS A 167HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.32A | 4n16A-4xz5A:30.0 | 4n16A-4xz5A:32.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | ALA A 78SER A 79SER A 126LYS A 216THR A 217GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.55A | 4n9kA-4k0xA:19.5 | 4n9kA-4k0xA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | ALA A 78SER A 79SER A 126LYS A 216THR A 217GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.53A | 4n9kB-4k0xA:19.3 | 4n9kB-4k0xA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OT2_A_ACTA605_0 (SERUM ALBUMIN) |
5nth | PUTATIVEAMINOPEPTIDASE (Leishmaniamajor) | 3 / 3 | LYS A 311LYS A 299ALA A 390 | BB2 A 604 ( 2.6A) MN A 602 ( 2.0A)BCT A 601 (-3.6A) | 1.14A | 4ot2A-5nthA:1.0 | 4ot2A-5nthA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OU1_A_BEZA302_0 (RETRO-ALDOLASE,DESIGN RA114) |
2ist | RIBOSOMAL LARGESUBUNITPSEUDOURIDINESYNTHASE D (Escherichiacoli) | 4 / 8 | TYR A 122ILE A 86ILE A 94LYS A 150 | BCT A 804 ( 4.3A)NoneNoneNone | 0.98A | 4ou1A-2istA:undetectable | 4ou1A-2istA:22.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PXX_A_CHDA302_0 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.26A | 4pxxA-4xz5A:29.8 | 4pxxA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWL_A_ASCA303_0 (DIOSCORIN 5) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 186VAL A 196THR A 252TRP A 262 | ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.7A)None | 0.21A | 4twlA-4xz5A:30.0 | 4twlA-4xz5A:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4TWL_B_ASCB304_0 (DIOSCORIN 5) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 186VAL A 196THR A 252TRP A 262 | ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.7A)None | 0.22A | 4twlB-4xz5A:30.2 | 4twlB-4xz5A:35.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_A_AZMA299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.12A | 4uovA-4xz5A:34.3 | 4uovA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_A_AZMA299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 4uovA-4xz5A:34.3 | 4uovA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_A_AZMA299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 4uovA-4xz5A:34.3 | 4uovA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_A_AZMA299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.98A | 4uovA-4xz5A:34.3 | 4uovA-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_B_AZMB299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.11A | 4uovB-4xz5A:34.4 | 4uovB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_B_AZMB299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.26A | 4uovB-4xz5A:34.4 | 4uovB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_B_AZMB299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.50A | 4uovB-4xz5A:34.4 | 4uovB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_B_AZMB299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.94A | 4uovB-4xz5A:34.4 | 4uovB-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_C_AZMC299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.12A | 4uovC-4xz5A:34.3 | 4uovC-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_C_AZMC299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.30A | 4uovC-4xz5A:34.3 | 4uovC-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_C_AZMC299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.97A | 4uovC-4xz5A:34.3 | 4uovC-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_D_AZMD299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.11A | 4uovD-4xz5A:34.4 | 4uovD-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_D_AZMD299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 4uovD-4xz5A:34.4 | 4uovD-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_D_AZMD299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 4uovD-4xz5A:34.4 | 4uovD-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_D_AZMD299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.96A | 4uovD-4xz5A:34.4 | 4uovD-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_E_AZME299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.12A | 4uovE-4xz5A:34.3 | 4uovE-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_E_AZME299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 4uovE-4xz5A:34.3 | 4uovE-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_E_AZME299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.95A | 4uovE-4xz5A:34.3 | 4uovE-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_E_AZME299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.46A | 4uovE-4xz5A:34.3 | 4uovE-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_F_AZMF299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.10A | 4uovF-4xz5A:34.4 | 4uovF-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_F_AZMF299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 4uovF-4xz5A:34.4 | 4uovF-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_F_AZMF299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 4uovF-4xz5A:34.4 | 4uovF-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UOV_F_AZMF299_1 (CARBONATEDEHYDRATASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.95A | 4uovF-4xz5A:34.4 | 4uovF-4xz5A:42.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_A_AZMA302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.29A | 4x5sA-4xz5A:32.7 | 4x5sA-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_A_AZMA302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 4x5sA-4xz5A:32.7 | 4x5sA-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_A_AZMA302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.91A | 4x5sA-4xz5A:32.7 | 4x5sA-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_A_AZMA302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.41A | 4x5sA-4xz5A:32.7 | 4x5sA-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_B_AZMB302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.29A | 4x5sB-4xz5A:32.8 | 4x5sB-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_B_AZMB302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 4x5sB-4xz5A:32.8 | 4x5sB-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_B_AZMB302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.92A | 4x5sB-4xz5A:32.8 | 4x5sB-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4X5S_B_AZMB302_1 (CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.41A | 4x5sB-4xz5A:32.8 | 4x5sB-4xz5A:42.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_A_AZMA402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.34A | 4xiwA-4xz5A:28.44xiwH-4xz5A:28.6 | 4xiwA-4xz5A:40.804xiwH-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_A_AZMA402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.95A | 4xiwA-4xz5A:28.44xiwH-4xz5A:28.6 | 4xiwA-4xz5A:40.804xiwH-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_A_AZMA402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.45A | 4xiwA-4xz5A:28.44xiwH-4xz5A:28.6 | 4xiwA-4xz5A:40.804xiwH-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_B_AZMB402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.33A | 4xiwB-4xz5A:28.54xiwE-4xz5A:28.5 | 4xiwB-4xz5A:40.804xiwE-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_B_AZMB402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.88A | 4xiwB-4xz5A:28.54xiwE-4xz5A:28.5 | 4xiwB-4xz5A:40.804xiwE-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_B_AZMB402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.42A | 4xiwB-4xz5A:28.54xiwE-4xz5A:28.5 | 4xiwB-4xz5A:40.804xiwE-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_C_AZMC402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.40A | 4xiwC-4xz5A:28.2 | 4xiwC-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_C_AZMC402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.94A | 4xiwC-4xz5A:28.2 | 4xiwC-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_D_AZMD402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 4xiwD-4xz5A:28.8 | 4xiwD-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_D_AZMD402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.99A | 4xiwD-4xz5A:28.8 | 4xiwD-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_E_AZME402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.33A | 4xiwE-4xz5A:28.5 | 4xiwE-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_E_AZME402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 4xiwE-4xz5A:28.5 | 4xiwE-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_E_AZME402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.45A | 4xiwE-4xz5A:28.5 | 4xiwE-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_F_AZMF402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.29A | 4xiwF-4xz5A:28.5 | 4xiwF-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_F_AZMF402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.46A | 4xiwF-4xz5A:28.5 | 4xiwF-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_F_AZMF402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.89A | 4xiwF-4xz5A:28.5 | 4xiwF-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_G_AZMG402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 12 / 12 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 194VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.42A | 4xiwG-4xz5A:28.6 | 4xiwG-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_G_AZMG402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 194LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.15A | 4xiwG-4xz5A:28.6 | 4xiwG-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_H_AZMH402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.36A | 4xiwH-4xz5A:28.6 | 4xiwH-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XIW_H_AZMH402_1 (CARBONIC ANHYDRASE,ALPHA TYPE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.86A | 4xiwH-4xz5A:28.6 | 4xiwH-4xz5A:40.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_A_AZMA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 11 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.36A | 4ygfA-4xz5A:29.6 | 4ygfA-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_B_AZMB303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 11 | HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.28A | 4ygfB-4xz5A:29.8 | 4ygfB-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_B_AZMB303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.45A | 4ygfB-4xz5A:29.8 | 4ygfB-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_B_AZMB303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 167HIS A 165VAL A 186LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.45A | 4ygfB-4xz5A:29.8 | 4ygfB-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_C_AZMC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 11 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.29A | 4ygfC-4xz5A:21.5 | 4ygfC-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_D_AZMD303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 11 | HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.28A | 4ygfD-4xz5A:4.6 | 4ygfD-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_D_AZMD303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.08A | 4ygfD-4xz5A:4.6 | 4ygfD-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_D_AZMD303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.37A | 4ygfD-4xz5A:4.6 | 4ygfD-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_E_AZME303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.30A | 4ygfE-4xz5A:29.8 | 4ygfE-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_F_AZMF303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 9 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.29A | 4ygfF-4xz5A:29.4 | 4ygfF-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_F_AZMF303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.50A | 4ygfF-4xz5A:29.4 | 4ygfF-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_F_AZMF303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.43A | 4ygfF-4xz5A:29.4 | 4ygfF-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_G_AZMG303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.28A | 4ygfG-4xz5A:6.8 | 4ygfG-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_H_AZMH303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 9 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.31A | 4ygfH-4xz5A:29.6 | 4ygfH-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YGF_H_AZMH303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167HIS A 165VAL A 186LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.41A | 4ygfH-4xz5A:29.6 | 4ygfH-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_A_MZMA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.47A | 4yhaA-4xz5A:29.5 | 4yhaA-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_A_MZMA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.09A | 4yhaA-4xz5A:29.5 | 4yhaA-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_B_MZMB303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 0.51A | 4yhaB-4xz5A:28.7 | 4yhaB-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_C_MZMC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 11 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.38A | 4yhaC-4xz5A:29.8 | 4yhaC-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_C_MZMC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.18A | 4yhaC-4xz5A:29.8 | 4yhaC-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_D_MZMD302_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 11 | HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.34A | 4yhaD-4xz5A:28.4 | 4yhaD-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_D_MZMD302_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.10A | 4yhaD-4xz5A:28.4 | 4yhaD-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_E_MZME303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 12 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 0.43A | 4yhaE-4xz5A:29.9 | 4yhaE-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_E_MZME303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165HIS A 184LEU A 251THR A 252PRO A 254TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 1.42A | 4yhaE-4xz5A:29.9 | 4yhaE-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_E_MZME303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 1.48A | 4yhaE-4xz5A:29.9 | 4yhaE-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_E_MZME303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252PRO A 255 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.16A | 4yhaE-4xz5A:29.9 | 4yhaE-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_F_MZMF302_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.61A | 4yhaF-4xz5A:27.0 | 4yhaF-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_G_MZMG303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 12 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.37A | 4yhaG-4xz5A:29.1 | 4yhaG-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_G_MZMG303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.49A | 4yhaG-4xz5A:29.1 | 4yhaG-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_G_MZMG303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.13A | 4yhaG-4xz5A:29.1 | 4yhaG-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_H_MZMH303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 10 | HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.33A | 4yhaH-4xz5A:29.4 | 4yhaH-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YHA_H_MZMH303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.03A | 4yhaH-4xz5A:29.4 | 4yhaH-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVP_B_GBMB402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C1) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TYR A 60TRP A 90HIS A 121ASN A 167LEU A 295 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-4.8A) | 0.55A | 4yvpB-2bgsA:40.2 | 4yvpB-2bgsA:34.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVV_A_GBMA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 9 | TYR A 60TRP A 90HIS A 121ASN A 167TYR A 214 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NDP A1321 (-3.3A)NDP A1321 (-3.3A) | 0.21A | 4yvvA-2bgsA:39.7 | 4yvvA-2bgsA:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_A_GMRA401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TYR A 60TRP A 90HIS A 121LEU A 126ASN A 167 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NoneNDP A1321 (-3.3A) | 0.22A | 4yvxA-2bgsA:39.5 | 4yvxA-2bgsA:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YVX_B_GMRB401_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C3) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 5 / 12 | TYR A 60TRP A 90HIS A 121LEU A 126ASN A 167 | BCT A1322 ( 4.4A)NoneBCT A1322 ( 3.9A)NoneNDP A1321 (-3.3A) | 0.19A | 4yvxB-2bgsA:39.3 | 4yvxB-2bgsA:34.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5C8I_A_MZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 252THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.19A | 5c8iA-4xz5A:29.8 | 5c8iA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5C8I_A_MZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | GLN A 163HIS A 165HIS A 167GLU A 171VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.41A | 5c8iA-4xz5A:29.8 | 5c8iA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5C8I_A_MZMA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165VAL A 196LEU A 251THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)NoneNone | 1.27A | 5c8iA-4xz5A:29.8 | 5c8iA-4xz5A:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D4N_C_ACTC201_0 (NITROGEN REGULATORYPROTEIN P-II) |
5d4o | NITROGEN REGULATORYPROTEIN P-II (Thiomonasintermedia) | 4 / 5 | VAL A 100GLY A 101ARG A 102PHE A 106 | BCT A 202 (-3.5A)BCT A 202 (-3.5A)BCT A 202 (-3.7A)AMP A 203 (-4.3A) | 0.35A | 5d4nA-5d4oA:21.25d4nC-5d4oA:17.4 | 5d4nA-5d4oA:100.005d4nC-5d4oA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | ALA A 78SER A 79SER A 126LYS A 216GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.53A | 5ghyA-4k0xA:19.6 | 5ghyA-4k0xA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | ALA A 78SER A 79SER A 126LYS A 216GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.52A | 5ghyB-4k0xA:19.4 | 5ghyB-4k0xA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 11 | ALA A 78SER A 79SER A 126LYS A 216THR A 217GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.52A | 5ghzA-4k0xA:19.4 | 5ghzA-4k0xA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 10 | ALA A 78SER A 79SER A 126LYS A 216THR A 217GLY A 218ARG A 259 | NoneKCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)BCT A 301 (-3.0A) | 0.54A | 5ghzB-4k0xA:19.3 | 5ghzB-4k0xA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HQA_A_ACRA705_2 (ALPHA-GLUCOSIDASE) |
5lhk | LEUCINEAMINOPEPTIDASE 2,CHLOROPLASTIC (Streptomycessp.BC16019) | 4 / 8 | ASN A 344GLU A 420HIS A 438THR A 373 | BCT A 603 (-4.0A)NoneNoneNone | 1.29A | 5hqaA-5lhkA:undetectable | 5hqaA-5lhkA:22.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_A_AZMA701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.38A | 5jn8A-4xz5A:27.3 | 5jn8A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_A_AZMA701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 165HIS A 167VAL A 186LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.16A | 5jn8A-4xz5A:27.3 | 5jn8A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_A_AZMA701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 10 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.50A | 5jn8A-4xz5A:27.3 | 5jn8A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_A_AZMA701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.04A | 5jn8A-4xz5A:27.3 | 5jn8A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_B_AZMB701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.16A | 5jn8B-4xz5A:27.5 | 5jn8B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_B_AZMB701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.39A | 5jn8B-4xz5A:27.5 | 5jn8B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_B_AZMB701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.98A | 5jn8B-4xz5A:27.5 | 5jn8B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_C_AZMC701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.36A | 5jn8C-4xz5A:27.1 | 5jn8C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_C_AZMC701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.17A | 5jn8C-4xz5A:27.1 | 5jn8C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_D_AZMD701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.31A | 5jn8D-4xz5A:26.8 | 5jn8D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_D_AZMD701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.96A | 5jn8D-4xz5A:26.8 | 5jn8D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN8_D_AZMD701_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.47A | 5jn8D-4xz5A:26.8 | 5jn8D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_A_EZLA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.39A | 5jn9A-4xz5A:27.3 | 5jn9A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_A_EZLA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.36A | 5jn9A-4xz5A:27.3 | 5jn9A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_A_EZLA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.05A | 5jn9A-4xz5A:27.3 | 5jn9A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_B_EZLB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.38A | 5jn9B-4xz5A:27.6 | 5jn9B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_B_EZLB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.35A | 5jn9B-4xz5A:27.6 | 5jn9B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_B_EZLB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.94A | 5jn9B-4xz5A:27.6 | 5jn9B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_C_EZLC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.33A | 5jn9C-4xz5A:27.1 | 5jn9C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_C_EZLC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.43A | 5jn9C-4xz5A:27.1 | 5jn9C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_C_EZLC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.34A | 5jn9C-4xz5A:27.1 | 5jn9C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_C_EZLC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.13A | 5jn9C-4xz5A:27.1 | 5jn9C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_C_EZLC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.45A | 5jn9C-4xz5A:27.1 | 5jn9C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_D_EZLD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.34A | 5jn9D-4xz5A:26.8 | 5jn9D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_D_EZLD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.31A | 5jn9D-4xz5A:26.8 | 5jn9D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JN9_D_EZLD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.13A | 5jn9D-4xz5A:26.8 | 5jn9D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_A_TORA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.48A | 5jnaA-4xz5A:27.3 | 5jnaA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_A_TORA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 143HIS A 165HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.26A | 5jnaA-4xz5A:27.3 | 5jnaA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_A_TORA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.46A | 5jnaA-4xz5A:27.3 | 5jnaA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_A_TORA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165HIS A 167GLU A 171VAL A 186LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.27A | 5jnaA-4xz5A:27.3 | 5jnaA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_A_TORA302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 167GLU A 171VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.97A | 5jnaA-4xz5A:27.3 | 5jnaA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_B_TORB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.46A | 5jnaB-4xz5A:27.6 | 5jnaB-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_B_TORB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | GLN A 143HIS A 165HIS A 167HIS A 184THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 ( 4.4A) | 1.08A | 5jnaB-4xz5A:27.6 | 5jnaB-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_B_TORB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.47A | 5jnaB-4xz5A:27.6 | 5jnaB-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_C_TORC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 11 | ASN A 138GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.48A | 5jnaC-4xz5A:27.0 | 5jnaC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_C_TORC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 165HIS A 167VAL A 186THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.07A | 5jnaC-4xz5A:27.0 | 5jnaC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_C_TORC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 11 | GLN A 163HIS A 165HIS A 167VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.43A | 5jnaC-4xz5A:27.0 | 5jnaC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_C_TORC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 165HIS A 167VAL A 186LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.16A | 5jnaC-4xz5A:27.0 | 5jnaC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_C_TORC302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.04A | 5jnaC-4xz5A:27.0 | 5jnaC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_D_TORD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | ASN A 138GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.43A | 5jnaD-4xz5A:26.8 | 5jnaD-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_D_TORD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | GLN A 143HIS A 165HIS A 167VAL A 186THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 ( 4.4A) | 1.08A | 5jnaD-4xz5A:26.8 | 5jnaD-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_D_TORD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165HIS A 167VAL A 186LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.10A | 5jnaD-4xz5A:26.8 | 5jnaD-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNA_D_TORD302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.49A | 5jnaD-4xz5A:26.8 | 5jnaD-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_A_6LHA302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 143HIS A 167GLU A 171VAL A 186THR A 253 | None ZN A 401 ( 3.3A) ZN A 401 ( 4.5A)NoneBCT A 402 ( 4.4A) | 1.19A | 5jncA-4xz5A:27.3 | 5jncA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_A_6LHA302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 11 | GLN A 163HIS A 165GLU A 182VAL A 186THR A 252 | None ZN A 401 ( 3.2A)NoneNoneBCT A 402 (-3.7A) | 1.30A | 5jncA-4xz5A:27.3 | 5jncA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_A_6LHA302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 11 | GLN A 163HIS A 165HIS A 167GLU A 171HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 4.5A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.41A | 5jncA-4xz5A:27.3 | 5jncA-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_B_6LHB302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 5jncB-4xz5A:27.6 | 5jncB-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_B_6LHB302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.11A | 5jncB-4xz5A:27.6 | 5jncB-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_B_6LHB302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.42A | 5jncB-4xz5A:27.6 | 5jncB-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_C_6LHC302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.32A | 5jncC-4xz5A:27.0 | 5jncC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_C_6LHC302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.00A | 5jncC-4xz5A:27.0 | 5jncC-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_D_6LHD302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.28A | 5jncD-4xz5A:26.8 | 5jncD-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JNC_D_6LHD302_0 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 9 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.13A | 5jncD-4xz5A:26.8 | 5jncD-4xz5A:31.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KB6_A_ADNA401_1 (ADENOSINE KINASE) |
4q2h | PROLINE RACEMASEPROTEIN (Agrobacteriumtumefaciens) | 5 / 12 | THR A 257GLY A 173VAL A 147ALA A 91ILE A 222 | BCT A 401 (-2.8A)NoneNoneNoneNone | 0.88A | 5kb6A-4q2hA:undetectable | 5kb6A-4q2hA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KB6_B_ADNB401_1 (ADENOSINE KINASE) |
4q2h | PROLINE RACEMASEPROTEIN (Agrobacteriumtumefaciens) | 5 / 12 | THR A 257GLY A 173VAL A 147ALA A 91ILE A 222 | BCT A 401 (-2.8A)NoneNoneNoneNone | 0.88A | 5kb6B-4q2hA:undetectable | 5kb6B-4q2hA:23.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_A_MZMA301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.39A | 5ku6A-4xz5A:27.3 | 5ku6A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_A_MZMA301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167HIS A 165THR A 253THR A 252TRP A 78 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.35A | 5ku6A-4xz5A:27.3 | 5ku6A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_A_MZMA301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.04A | 5ku6A-4xz5A:27.3 | 5ku6A-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_B_MZMB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 10 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.35A | 5ku6B-4xz5A:27.6 | 5ku6B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_B_MZMB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.12A | 5ku6B-4xz5A:27.6 | 5ku6B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_B_MZMB302_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.46A | 5ku6B-4xz5A:27.6 | 5ku6B-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_C_MZMC301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.35A | 5ku6C-4xz5A:27.1 | 5ku6C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_C_MZMC301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.05A | 5ku6C-4xz5A:27.1 | 5ku6C-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_D_MZMD301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 9 | GLN A 163HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.33A | 5ku6D-4xz5A:26.9 | 5ku6D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_D_MZMD301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167VAL A 196LEU A 251THR A 252THR A 253 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.02A | 5ku6D-4xz5A:26.9 | 5ku6D-4xz5A:31.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KU6_D_MZMD301_1 (CARBONIC ANHYDRASE 4) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 184HIS A 167VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.1A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.47A | 5ku6D-4xz5A:26.9 | 5ku6D-4xz5A:31.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M78_A_SALA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 7 | GLN A 163HIS A 165VAL A 186LEU A 251THR A 252THR A 253 | None ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.32A | 5m78A-4xz5A:29.7 | 5m78A-4xz5A:16.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M78_A_SALA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 7 | GLN A 163HIS A 165VAL A 186LEU A 251THR A 253 | None ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.38A | 5m78A-4xz5A:29.7 | 5m78A-4xz5A:16.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M78_A_SALA304_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 7 | VAL A 196LEU A 251THR A 252THR A 253 | NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 0.93A | 5m78A-4xz5A:29.7 | 5m78A-4xz5A:16.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MUR_B_PFLB407_1 (PROTON-GATED IONCHANNEL) |
2i4c | BICARBONATETRANSPORTER (Synechocystissp.PCC6803) | 4 / 7 | PRO A 224ILE A 68ILE A 66THR A 192 | NoneBCT A 460 (-4.5A)NoneBCT A 460 (-2.7A) | 0.91A | 5murB-2i4cA:undetectable | 5murB-2i4cA:13.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OGJ_A_ACTA307_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 6 | HIS A 165HIS A 167LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.26A | 5ogjA-4xz5A:29.6 | 5ogjA-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OGJ_A_ACTA307_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 6 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.28A | 5ogjA-4xz5A:29.6 | 5ogjA-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OGJ_A_ACTA307_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 6 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.50A | 5ogjA-4xz5A:29.6 | 5ogjA-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OGJ_B_ACTB305_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 6 | HIS A 165HIS A 167LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.26A | 5ogjB-4xz5A:29.2 | 5ogjB-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OGJ_B_ACTB305_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 6 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.26A | 5ogjB-4xz5A:29.2 | 5ogjB-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OGJ_B_ACTB305_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 6 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.50A | 5ogjB-4xz5A:29.2 | 5ogjB-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OHH_A_ACTA307_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 5 | HIS A 165HIS A 167LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.27A | 5ohhA-4xz5A:29.2 | 5ohhA-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OHH_A_ACTA307_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 5 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 0.19A | 5ohhA-4xz5A:29.2 | 5ohhA-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OHH_B_ACTB311_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 4 / 6 | HIS A 165HIS A 167LEU A 251THR A 253 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 ( 4.4A) | 1.26A | 5ohhB-4xz5A:29.5 | 5ohhB-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OHH_B_ACTB311_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 6 | HIS A 165HIS A 184VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.27A | 5ohhB-4xz5A:29.5 | 5ohhB-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5OHH_B_ACTB311_0 (CARBONIC ANHYDRASE13) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 6 | HIS A 167HIS A 184LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.49A | 5ohhB-4xz5A:29.5 | 5ohhB-4xz5A:31.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_A_EZLA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 0.45A | 5tt3A-4xz5A:29.6 | 5tt3A-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_A_EZLA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 165HIS A 167VAL A 186LEU A 251PRO A 255 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)None | 1.07A | 5tt3A-4xz5A:29.6 | 5tt3A-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_A_EZLA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 165HIS A 184THR A 252PRO A 254TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.7A)NoneNone | 1.31A | 5tt3A-4xz5A:29.6 | 5tt3A-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_A_EZLA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 165HIS A 184VAL A 196LEU A 251PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)NoneNone | 1.48A | 5tt3A-4xz5A:29.6 | 5tt3A-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_A_EZLA303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 10 | HIS A 167VAL A 196LEU A 251THR A 252PRO A 255 | ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.22A | 5tt3A-4xz5A:29.6 | 5tt3A-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_B_EZLB303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 9 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.39A | 5tt3B-4xz5A:27.6 | 5tt3B-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_C_EZLC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 9 / 10 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 0.34A | 5tt3C-4xz5A:29.9 | 5tt3C-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_C_EZLC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 165HIS A 184LEU A 251THR A 252PRO A 254TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)NoneNone | 1.47A | 5tt3C-4xz5A:29.9 | 5tt3C-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_C_EZLC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 165HIS A 184VAL A 196LEU A 251PRO A 255TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)NoneNone | 1.39A | 5tt3C-4xz5A:29.9 | 5tt3C-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_C_EZLC303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 10 | HIS A 167HIS A 165VAL A 186LEU A 251THR A 252PRO A 255 | ZN A 401 ( 3.3A) ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 1.45A | 5tt3C-4xz5A:29.9 | 5tt3C-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_E_EZLE303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 9 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.32A | 5tt3E-4xz5A:29.8 | 5tt3E-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_E_EZLE303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.01A | 5tt3E-4xz5A:29.8 | 5tt3E-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_F_EZLF302_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 8 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.44A | 5tt3F-4xz5A:28.9 | 5tt3F-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_F_EZLF302_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 8 | HIS A 165HIS A 184VAL A 196LEU A 251TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)None | 1.42A | 5tt3F-4xz5A:28.9 | 5tt3F-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_G_EZLG303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 8 / 9 | HIS A 165HIS A 167HIS A 184VAL A 186VAL A 196LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.34A | 5tt3G-4xz5A:28.7 | 5tt3G-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_G_EZLG303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 9 | HIS A 167HIS A 184VAL A 196LEU A 251THR A 252 | ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A) | 1.02A | 5tt3G-4xz5A:28.7 | 5tt3G-4xz5A:35.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TT3_H_EZLH303_1 (ALPHA-CARBONICANHYDRASE) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 8 | HIS A 165HIS A 167HIS A 184VAL A 186LEU A 251THR A 252TRP A 262 | ZN A 401 ( 3.2A) ZN A 401 ( 3.3A) ZN A 401 ( 3.1A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)None | 0.40A | 5tt3H-4xz5A:29.0 | 5tt3H-4xz5A:35.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_A_ACTA310_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) |
4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) | 3 / 3 | GLU A 740HIS A 741ARG A 839 | NoneNoneBCT A3006 (-4.0A) | 0.93A | 5uunA-4yswA:undetectable | 5uunA-4yswA:12.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.88A | 6b5yB-4k0xA:19.1 | 6b5yB-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.75A | 6b5yD-4k0xA:19.2 | 6b5yD-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.64A | 6b68B-4k0xA:19.3 | 6b68B-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_D_9F2D400_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126ARG A 259LYS A 216GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.4A)None | 0.89A | 6b68D-4k0xA:19.3 | 6b68D-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.59A | 6b69A-4k0xA:19.26b69B-4k0xA:19.2 | 6b69A-4k0xA:16.156b69B-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A) | 0.75A | 6b69D-4k0xA:19.2 | 6b69D-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.82A | 6b6aB-4k0xA:19.1 | 6b6aB-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 7 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.80A | 6b6aD-4k0xA:19.1 | 6b6aD-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A) | 0.83A | 6b6cA-4k0xA:19.3 | 6b6cA-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126ARG A 259LYS A 216THR A 217GLY A 218 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A) | 0.78A | 6b6eA-4k0xA:19.2 | 6b6eA-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
4k0x | BETA-LACTAMASE (Acinetobacterbaumannii) | 6 / 12 | SER A 79SER A 126LYS A 216THR A 217GLY A 218ASP A 222 | KCX A 82 (-2.5A)BCT A 301 (-2.8A)BCT A 301 (-3.0A)BCT A 301 (-3.5A)BCT A 301 (-3.4A)None | 0.79A | 6b6fA-4k0xA:18.9 | 6b6fA-4k0xA:16.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BBS_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | GLN A 143HIS A 165HIS A 167LEU A 251THR A 252THR A 253 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A) | 1.18A | 6bbsA-4xz5A:24.9 | 6bbsA-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BBS_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 5 / 12 | HIS A 172HIS A 167THR A 253THR A 252TRP A 78 | None ZN A 401 ( 3.3A)BCT A 402 ( 4.4A)BCT A 402 (-3.7A)None | 1.24A | 6bbsA-4xz5A:24.9 | 6bbsA-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BBS_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | TRP A 78ASN A 138HIS A 140GLN A 163HIS A 165HIS A 167LEU A 251THR A 252THR A 253TRP A 262 | NoneNoneNoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 0.55A | 6bbsA-4xz5A:24.9 | 6bbsA-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BBS_A_BZ1A302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | TRP A 78HIS A 140HIS A 165THR A 252THR A 253TRP A 262 | NoneNone ZN A 401 ( 3.2A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.32A | 6bbsA-4xz5A:24.9 | 6bbsA-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 11 / 12 | TRP A 78ASN A 138GLN A 163HIS A 165HIS A 167VAL A 186LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | NoneNoneNone ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.45A | 6bc9A-4xz5A:29.8 | 6bc9A-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | TRP A 78HIS A 165LEU A 251THR A 253PRO A 255TRP A 262 | None ZN A 401 ( 3.2A)BCT A 402 (-3.8A)BCT A 402 ( 4.4A)NoneNone | 1.22A | 6bc9A-4xz5A:29.8 | 6bc9A-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | TRP A 78HIS A 167LEU A 251THR A 252THR A 253TRP A 262 | None ZN A 401 ( 3.3A)BCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.25A | 6bc9A-4xz5A:29.8 | 6bc9A-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | TRP A 78HIS A 167VAL A 196LEU A 251THR A 252THR A 253PRO A 255 | None ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)None | 1.14A | 6bc9A-4xz5A:29.8 | 6bc9A-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BC9_A_ETSA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 7 / 12 | TRP A 89HIS A 165HIS A 167VAL A 186LEU A 251THR A 253TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)None | 1.46A | 6bc9A-4xz5A:29.8 | 6bc9A-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BCC_A_EZLA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 10 / 12 | GLN A 163HIS A 165HIS A 167VAL A 186VAL A 196LEU A 251THR A 252THR A 253PRO A 255TRP A 262 | None ZN A 401 ( 3.2A) ZN A 401 ( 3.3A)NoneNoneBCT A 402 (-3.8A)BCT A 402 (-3.7A)BCT A 402 ( 4.4A)NoneNone | 0.38A | 6bccA-4xz5A:29.8 | 6bccA-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BCC_A_EZLA302_1 (CARBONIC ANHYDRASE 2) |
4xz5 | CARBONIC ANHYDRASE,ALPHA FAMILY (Hydrogenovibriocrunogenus) | 6 / 12 | HIS A 165VAL A 196LEU A 251THR A 253PRO A 255TRP A 262 | ZN A 401 ( 3.2A)NoneBCT A 402 (-3.8A)BCT A 402 ( 4.4A)NoneNone | 1.31A | 6bccA-4xz5A:29.8 | 6bccA-4xz5A:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BRD_B_RFPB502_2 (RIFAMPINMONOOXYGENASE) |
5bxi | NUCLEOSIDEDIPHOSPHATE KINASE (Toxoplasmagondii) | 4 / 6 | GLN A 32VAL A 152LEU A 106ARG A 90 | NoneNoneNoneBCT A 201 ( 4.9A) | 1.17A | 6brdB-5bxiA:undetectable | 6brdB-5bxiA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DYO_A_LDPA901_0 (EBONY) |
2bgs | ALDOSE REDUCTASE (Hordeumvulgare) | 4 / 5 | GLU A 221VAL A 294LEU A 295HIS A 121 | NoneNoneNDP A1321 (-4.8A)BCT A1322 ( 3.9A) | 1.19A | 6dyoA-2bgsA:undetectable | 6dyoA-2bgsA:15.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_A_BEZA502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5bxi | NUCLEOSIDEDIPHOSPHATE KINASE (Toxoplasmagondii) | 4 / 6 | VAL A 13LEU A 93LEU A 106ARG A 107 | NoneNoneNoneBCT A 201 (-4.6A) | 0.72A | 6e43A-5bxiA:undetectable | 6e43A-5bxiA:17.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_B_BEZB502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5bxi | NUCLEOSIDEDIPHOSPHATE KINASE (Toxoplasmagondii) | 4 / 6 | VAL A 13LEU A 93LEU A 106ARG A 107 | NoneNoneNoneBCT A 201 (-4.6A) | 0.73A | 6e43B-5bxiA:undetectable | 6e43B-5bxiA:17.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_C_BEZC502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5bxi | NUCLEOSIDEDIPHOSPHATE KINASE (Toxoplasmagondii) | 4 / 6 | VAL A 13LEU A 93LEU A 106ARG A 107 | NoneNoneNoneBCT A 201 (-4.6A) | 0.75A | 6e43C-5bxiA:undetectable | 6e43C-5bxiA:17.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_D_BEZD502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5bxi | NUCLEOSIDEDIPHOSPHATE KINASE (Toxoplasmagondii) | 4 / 6 | VAL A 13LEU A 93LEU A 106ARG A 107 | NoneNoneNoneBCT A 201 (-4.6A) | 0.82A | 6e43D-5bxiA:undetectable | 6e43D-5bxiA:17.28 |